IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 242 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,547,000 | +8.0% | 520,000 | 0.0% | 0.77% | +15.2% |
| Q4 2021 | $6,063,000 | -10.7% | 520,000 | 0.0% | 0.67% | -14.5% |
| Q3 2021 | $6,791,000 | +1.5% | 520,000 | 0.0% | 0.78% | +6.8% |
| Q2 2021 | $6,692,000 | +15.1% | 520,000 | 0.0% | 0.74% | +5.5% |
| Q1 2021 | $5,814,000 | +1.7% | 520,000 | +3.6% | 0.70% | -20.9% |
| Q4 2020 | $5,716,000 | +26.6% | 501,874 | 0.0% | 0.88% | +7.6% |
| Q3 2020 | $4,514,000 | +6.8% | 501,874 | +22.6% | 0.82% | +6.1% |
| Q2 2020 | $4,226,000 | +946.0% | 409,500 | +923.8% | 0.77% | +841.5% |
| Q1 2020 | $404,000 | +344.0% | 40,000 | +378.6% | 0.08% | +583.3% |
| Q2 2019 | $91,000 | – | 8,358 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $172,422,800 | 22.05% |
| 13D Management LLC | 533,562 | $5,613,073 | 2.85% |
| Quantedge Capital Pte Ltd | 541,200 | $5,693,424 | 2.22% |
| Price Jennifer C. | 520,000 | $5,470,400 | 1.74% |
| Tamarack Advisers, LP | 210,000 | $2,209,200 | 0.81% |
| Intrinsic Value Partners, LLC | 51,605 | $542,885 | 0.73% |
| Brown Capital Management | 3,933,933 | $41,384,975 | 0.62% |
| Old West Investment Management, LLC | 75,219 | $791,303 | 0.43% |
| EMC Capital Management | 43,315 | $456 | 0.38% |
| Hillsdale Investment Management Inc. | 420,617 | $4,424,891 | 0.38% |